US Patent Family Members and Approved Drugs for Greece Patent: 3025931
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Greece Patent: GR3025931
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 5,654,403 | 2014-08-05 | alemtuzumab | Genzyme Corporation | CAMPATH |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
